The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age
Open accessAbstract
Abstract The utility of X-inactivation based clonality assays for evaluation of human neoplasia is well-documented. However, excessive Lyonization is a potential limitation of these assays, because it mimics clonal derivation of cells. The incidence of excessive Lyonization in healthy females is controversial, with reported incidence varying from 4% to 33%. Several explanations have been offered for the observed variation, including different criteria for excessive Lyonization, diversity of X- linked clonality assays, small population sizes and more recently, tissue specificity of X-inactivation patterns. However, it is also possible that stem cell depletion, clonal hematopoiesis, or selection pressures on blood cells results in an increased incidence of excessive skewing. If any of the latter is true, then the incidence of excessive skewing should increase with age in blood cells. To test this hypothesis, we determined X-inactivation ratios at the human androgen receptor locus of 295 normal females from three age groups: (1) neonates, (2) females 28 to 32 years old and, (3) females aged > or = 60 years. The incidence of skewing (allele ratios > or = 3:1) was 8.6% (14 of 162) in neonates (P = .104 v 28 to 32); 16.4% (11/67) in 28 to 32 y.o. (P = .0064 v > or = 60), and 37.9% (25 of 66) in women > or = 60 y.o. (P < .0001 v neonates). When a more stringent criterion for skewing was used (allele ratios > or = 10:1), the incidence was 1.9% (3 of 162) in neonates (P = .362 v 28 to 32), 4.5% (3 of 67) in 28 to 32 y.o. (P = .0022 v > or = 60), and 22.7% (15 of 66) in > or = 60 y.o. group (P < .0001 v neonates). Results have been confirmed at the phosphoglycerate kinase locus for 48 heterozygous females. The incidence of excessive skewing increases with age. In neonates, the incidence is low and may correspond to true excessive Lyonization. Acquired skewing occurs with aging in normal females and is present in 38% of females over the age of 60. Further studies are needed to determine whether acquired skewing is a consequence of stem cell depletion, true clonal hematopoiesis, growth advantage conferred by parental-specific X-chromosomes, or other causes. These data provide an explanation for variation in reported incidence of excessive skewing in normal females. Furthermore, these findings suggest that any study of clonality using X-inactivation based assays should incorporate age- matched controls for Lyonization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“during aging, blood cells are derived from fewer and fewer stem cells.”
From Aging of hematopoietic stem cells (2018) · cites this paper as [79]
In the citing paper
“However, in some elderly individuals, HSCs acquire oncogenic mutations that allow them to outcompete their neighbors and clonally expand.”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Busque et al., 1996
In the citing paper
“As these HSCs clonally expand, they can account for a substantial fraction of steady state hematopoiesis, termed clonal hematopoiesis of indeterminate potential (CHIP) (Busque et al., 1996; Champion et al., 1997; Vas et al., 2012).”
From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Busque et al., 1996
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978
Allen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
Clonal origin of chronic myelocytic leukemia in man.
Fialkow, P., Gartler, S. M., & Yoshida, A. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.4.1468 · Cited by 532
Clonal analysis using recombinant DNA probes from the X-chromosome.
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Preisinger, A. C., Willard, H. F., Michelson, A. M., Riggs, A. D., & Orkin, S. H. (1987) · PubMed · Cited by 417
Catalog Of Mutant Genes And Polymorphic Loci
Doolitile, D. P., Davisson, M. T., Guidi, J. N., & Green, M. C. (1996) · doi:10.1093/oso/9780198548690.003.0002 · Cited by 400
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell
Fialkow, P., Faguet, G., Jacobson, R., Vaidya, K., & Murphy, S. (1981) · Blood · doi:10.1182/blood.v58.5.916.916 · Cited by 384
Use of Restriction Fragment Length Polymorphisms to Determine the Clonal Origin of Human Tumors
Vogelstein, B., Fearon, E. R., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2982210 · Cited by 379
Kay, G. F., Penny, G. D., Patel, D., Ashworth, A., Brockdorff, N., & Rastan, S. (1993) · Cell · doi:10.1016/0092-8674(93)90658-d · Cited by 364
“Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-Up
Kyle, R. A. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60015-9 · Cited by 344
Research works printed but not linked: 1
- Busque L, Gilliland DG: The PGK-PCR based clonality assay (PPCA), in Harwood AJ (ed): Methods in Molecular Biology: Proto- cols for Gene Analysis, vol 31. Totowa, NJ, Humana Press 1994, p 237
Cited by
Sorted by citations
Items 101–200 of 543
Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review
Pinto, L. L. D. C., Vieira, T. A., Giugliani, R., & Schwartz, I. V. D. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-14 · Cited by 81
Turning the tide in myelodysplastic/myeloproliferative neoplasms
Deininger, M. W., Tyner, J. W., & Solary, É. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.40 · Cited by 88
Yorifuji, T., Muroi, J., Uematsu, A., Tanaka, K., Kiwaki, K., Endo, F., Matsuda, I., Nagasaka, H., & Furusho, K. (1998) · Clinical Genetics · doi:10.1034/j.1399-0004.1998.5440415.x · Cited by 80
Anderson-Cohen, M., Holland, S. M., Kuhns, D. B., Fleisher, T. A., Ding, L., Brenner, S., Malech, H. L., & Roesler, J. (2003) · Clinical Immunology · doi:10.1016/j.clim.2003.08.002 · Cited by 79
Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil
Busque, L., Buscarlet, M., Mollica, L. R., & Levine, R. L. (2018) · Stem Cells · doi:10.1002/stem.2845 · Cited by 79
Self-citationRecent advances in the understanding of inherited sideroblastic anaemia
Camaschella, C. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07290.x · Cited by 79
Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy
Yoshioka, M., Yorifuji, T., & Mituyoshi, I. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb02655.x · Cited by 77
Heritability of skewed X-inactivation in female twins is tissue-specific and associated with age
Zito, A., Davies, M. N., Tsai, P.-C., Roberts, S., Ejarque, R. A., Nardone, S., Bell, J. T., Wong, C. C. Y., & Small, K. S. (2019) · Nature Communications · doi:10.1038/s41467-019-13340-w · Cited by 73
X Chromosome Inactivation in Carriers of Barth Syndrome
Ørstavik, K. H., Ørstavik, R., Naumova, A. K., D’Adamo, P., Gedeon, Á. K., Bolhuis, P. A., Barth, P. G., & Toniolo, D. (1998) · The American Journal of Human Genetics · doi:10.1086/302095 · Cited by 73
D’Aquila, P., Rose, G., Bellizzi, D., & Passarino, G. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.11.005 · Cited by 73
Ganuza, M., Hall, T., Finkelstein, D., Wang, Y., Chabot, A., Kang, G., Bi, W., Wu, G., & McKinney‐Freeman, S. (2019) · Blood · doi:10.1182/blood-2018-09-873059 · Cited by 73
Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human
Naumova, A. K., Olien, L., Bird, L. M., Smith, M. A., Verner, A., Leppert, M., Morgan, K. W., & Sapienza, C. (1998) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200255 · Cited by 70
Wang, J., Yu, R. K., & Shete, S. S. (2014) · Genetic Epidemiology · doi:10.1002/gepi.21814 · Cited by 72
Human Placental-Specific Epipolymorphism and its Association with Adverse Pregnancy Outcomes
Yuen, R. K. C., Avila, L., Peñaherrera, M. S., von Dadelszen, P., Lefebvre, L., Kobor, M. S., & Robinson, W. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007389 · Cited by 72
Extremely Skewed X-Chromosome Inactivation Is Increased in Women with Recurrent Spontaneous Abortion
Sangha, K. K., Stephenson, M. D., Brown, C. J., & Robinson, W. P. (1999) · The American Journal of Human Genetics · doi:10.1086/302552 · Cited by 72
The Longevity Gender Gap: Are Telomeres the Explanation?
Aviv, A., Shay, J. W., Christensen, K., & Wright, W. E. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.23.pe16 · Cited by 71
Nonsyndromic mental retardation and cryptogenic epilepsy in women with Doublecortin gene mutations
Guerrini, R., Moro, F., Andermann, E., Hughes, E., D’Agostino, D., Carrozzo, R., Bernasconi, A., Flinter, F. A., Parmeggiani, L., Volzone, A., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10588 · Cited by 71
Tanner, S. M., Ørstavik, K. H., Kristiansen, M. B., Lev, D., Lerman‐Sagie, T., Sadeh, M., & Liechti‐Gallati, S. (1999) · Human Genetics · doi:10.1007/s004390050943 · Cited by 70
Increased skewing of X chromosome inactivation with age in both blood and buccal cells
Knudsen, G. P., Pedersen, J. V., Klingenberg, O., Lygren, I., & Ørstavik, K. H. (2007) · Cytogenetic and Genome Research · doi:10.1159/000097414 · Cited by 66
Bojesen, A., Hertz, J. M., & Gravholt, C. H. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2011.01223.x · Cited by 67
Highly Skewed X-Chromosome Inactivation Is Associated with Idiopathic Recurrent Spontaneous Abortion
Lanasa, M. C., Hogge, W. A., Kubik, C. J., Blancato, J. K., & Hoffman, E. P. (1999) · The American Journal of Human Genetics · doi:10.1086/302441 · Cited by 67
Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
Yura, Y., Sano, S., & Walsh, K. X. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.08.006 · Cited by 69
Clonal Hematopoiesis and Its Impact on Human Health
Ahmad, H., Jahn, N., & Jaiswal, S. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-112347 · Cited by 66
Hematopoiesis is not clonal in healthy elderly women
Swierczek, S. I., Agarwal, N., Nussenzveig, R. H., Rothstein, G., Wilson, A. R., Artz, A. S., & Prchal, J. T. (2008) · Blood · doi:10.1182/blood-2008-03-143925 · Cited by 66
Clonal hematopoiesis as a model for premalignant changes during aging
Steensma, D. P., & Ebert, B. L. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.001 · Cited by 65
Alterations to DNMT3A in Hematologic Malignancies
Venugopal, K., Feng, Y., Shabashvili, D. E., & Guryanova, O. A. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-3033 · Cited by 70
Age-related clonal haemopoiesis is associated with increased epigenetic age
Robertson, N., Hillary, R. F., McCartney, D. L., Terradas-Terradas, M., Higham, J., Sproul, D., Deary, I. J., Kirschner, K., Marioni, R. E., & Chandra, T. (2019) · Current Biology · doi:10.1016/j.cub.2019.07.011 · Cited by 63
X-linked clonality testing: interpretation and limitations
Chen, G. L., & Prchal, J. T. (2007) · Blood · doi:10.1182/blood-2006-09-018655 · Cited by 64
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63
Preleukemia: one name, many meanings
Koeffler, H. P., & Leong, G. X. Y. (2016) · Leukemia · doi:10.1038/leu.2016.364 · Cited by 67
Clonal Hematopoiesis Before, During, and After Human Spaceflight
Mencia-Trinchant, N., MacKay, M. J., Chin, C. R., Afshinnekoo, E., Foox, J., Meydan, C., Butler, D., Mozsary, C., Vernice, N. A., Darby, C. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108458 · Cited by 62
A longitudinal study of X-inactivation ratio in human females
Sandovici, I., Naumova, A. K., Leppert, M., Linares, Y., & Sapienza, C. (2004) · Human Genetics · doi:10.1007/s00439-004-1177-8 · Cited by 62
Clonal hematopoiesis in patients with dyskeratosis congenita
Perdigones, N., Perin, J. C., Schiano, I., Nicholas, P., Biegel, J. A., Mason, P. J., Babushok, D. V., & Bessler, M. (2016) · American Journal of Hematology · doi:10.1002/ajh.24552 · Cited by 63
ASXL1 mutation in clonal hematopoiesis
Fujino, T., & Kitamura, T. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.002 · Cited by 64
Preferential X-chromosome inactivation in women with idiopathic recurrent pregnancy loss
Uehara, S., Hashiyada, M., Sato, K., Sato, Y., Fujimori, K., & Okamura, K. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02845-x · Cited by 62
Three New Loci for Determining X Chromosome Inactivation Patterns
Bertelsen, B., Tümer, Z., & Ravn, K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.05.003 · Cited by 61
X-Inactivation Patterns in Human Embryonic and Extra-embryonic Tissues
Zeng, S. M., & Yankowitz, J. (2003) · Placenta · doi:10.1053/plac.2002.0889 · Cited by 61
Assessment of mechanism of acquired skewed X inactivation by analysis of twins
Vickers, M. A., McLeod, E., Spector, T. D., & Wilson, I. (2001) · Blood · doi:10.1182/blood.v97.5.1274 · Cited by 60
The Clinical Management of Clonal Hematopoiesis
Bolton, K. L., Zehir, A., Ptashkin, R. N., Patel, M. A., Gupta, D., Sidlow, R., Papaemmanuil, E., Berger, M. F., & Levine, R. L. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.11.006 · Cited by 60
Lexner, M., Bardow, A., Juncker, I., Jensen, L., Almer, L., Kreiborg, S., & Hertz, J. M. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01037.x · Cited by 62
A novel X chromosome–linked genetic cause of recurrent spontaneous abortion
Lanasa, M. C., Hogge, W. A., Kubik, C. J., Ness, R. B., Harger, J. H., Nagel, T. C., Prosen, T. L., Marković, N., & Hoffman, E. P. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117670 · Cited by 59
Renault, N., Pritchett, S. M., Howell, R. E., Greer, W. L., Sapienza, C., Ørstavik, K. H., & Hamilton, D. C. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.84 · Cited by 58
Evidence of clonality in chronic neutrophilic leukaemia
Böhm, J., Kock, S., Schaefer, H. E., & Fisch, P. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.4.292 · Cited by 58
Increased skewing of X chromosome inactivation in Rett syndrome patients and their mothers
Knudsen, G. P. S., Neilson, T. C. S., Pedersen, J., Kerr, A., Schwartz, M., Hulten, M., Bailey, M. E. S., & Ørstavik, K. H. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201682 · Cited by 58
Genetic drivers and cellular selection of female mosaic X chromosome loss
Liu, A., Genovese, G., Zhao, Y., Pirinen, M., Zekavat, S. M., Kentistou, K. A., Yang, Z., Yu, K. F., Vlasschaert, C., Liu, X., et al. (2024) · Nature · doi:10.1038/s41586-024-07533-7 · Cited by 67
Overexpression of the Polycythemia Rubra Vera-1 Gene in Essential Thrombocythemia
Teofili, L., Martini, M., Luongo, M., Mario, A. D., Leone, G. G. M., Stefano, V. D., & Larocca, L. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.507 · Cited by 57
Clonal hemopoiesis and risk of thrombosis in young female patients with essential thrombocythemia
Chiusolo, P., Barbera, E. O. L., Laurenti, L., Piccirillo, N., Sorà, F., Giordano, G., Urbano, R., Mazzucconi, M. G., Stefano, V. D., Leone, G. G. M., et al. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00640-3 · Cited by 57
Analysis of X chromosome inactivation in autism spectrum disorders
Gong, X., Bacchelli, E., Blasi, F., Claudio Toma, A., Betancur, C., Chaste, P., Delorme, R., Durand, C. M., Fauchereau, F., Goubran‐Botros, H., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30688 · Cited by 59
Ishiyama, K., Chuhjo, T., Wang, H., Yachie, A., Omine, M., & Nakao, S. (2003) · Blood · doi:10.1182/blood-2002-12-3706 · Cited by 55
Hardwick, S. A., Reuter, K., Williamson, S. L., Vasudevan, V., Donald, J. A., Slater, K., Bennetts, B., Bebbington, A., Leonard, H., Williams, S. R., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201911 · Cited by 54
Kassar, N. E., Hetet, G., Brière, J.-J., & Grandchamp, B. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.1.61 · Cited by 54
Clonal hematopoiesis and hematological malignancy
Dunn, W. G., McLoughlin, M. A., & Vassiliou, G. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180065 · Cited by 63
Methylation of AR locus does not always reflect X chromosome inactivation state
Swierczek, S. I., Lanikova, L., Jelı́nek, J., Agarwal, N., Hammoud, S. S., Wilson, A. R., Hickman, K., Parker, C. J., Cairns, B. R., & Prchal, J. T. (2012) · Blood · doi:10.1182/blood-2011-11-390351 · Cited by 53
Gentilini, D., Castaldi, D., Mari, D., Monti, D., Franceschi, C., Blasio, A. M. D., & Vitale, G. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00790.x · Cited by 53
Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality
Hansen, J. W., Pedersen, D. A., Larsen, L. A., Husby, S., Clemmensen, S. B., Hjelmborg, J., Favero, F., Weischenfeldt, J., Christensen, K., & Grønbæk, K. (2019) · Blood · doi:10.1182/blood.2019001793 · Cited by 53
MAGRO, C. M. J., Moraes, E. D., & Burns, F. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.280205.x · Cited by 53
Scheibel, E., Ingerslev, J., Schwartz, M., & Örstavik, K. H. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613833 · Cited by 51
Skewed X inactivation in healthy individuals and in different diseases
Ørstavik, K. H. (2006) · Acta Paediatrica · doi:10.1080/08035320600618783 · Cited by 53
Aivado, M. A., Gattermann, N., Rong, A., Giagounidis, A. A. N., Prall, W. C., Czibere, A. G., Hildebrandt, B., Haas, R., & Bottomley, S. S. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.04.003 · Cited by 52
Sakata, A., Mogi, M., Iwanami, J., Tsukuda, K., Min, L., Fujita, T., Iwai, M., Ito, M., & Horiuchi, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.068 · Cited by 51
Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined
Elliott, M. A. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.07.012 · Cited by 51
X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis
Viggiano, E., & Politano, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147663 · Cited by 51
Bernard, T., Gale, R. E., Evans, J. P. M., & Linch, D. C. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00652.x · Cited by 51
Thornley, I., Sutherland, R., Wynn, R. F., Nayar, R., Sung, L., Corpus, G., Kiss, T. L., Lipton, J. H., Doyle, J., Saunders, F., et al. (2002) · Blood · doi:10.1182/blood.v99.7.2387 · Cited by 51
Mach‐Pascual, S., Legare, R. D., Lu, D., Kroon, M., Neuberg, D. S., Tantravahi, R. V., Stone, R. M., Freedman, A. S., Nadler, L. M., Gribben, J. G., et al. (1998) · Blood · doi:10.1182/blood.v91.12.4496 · Cited by 51
Self-citationSkewed X-Chromosome Inactivation in Scleroderma
Uz, E., Loubière, L. S., Gadi, V. K., Özbalkan, Z., Stewart, J. J., Nelson, J. L., & Özçelık, T. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8044-z · Cited by 50
Tissue control of androgen action: The ups and downs of androgen receptor expression
Hunter, I., Hay, C. W., Eßwein, B., Watt, K., & McEwan, I. J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.002 · Cited by 52
A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy
Hammans, S. R., Robinson, D., Moutou, C., Kennedy, C., Dennis, N. R., Hughes, P., & Ellison, D. W. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00073-5 · Cited by 50
Cytogenetic and Molecular Genetic Aspects of Essential Thrombocythemia
Steensma, D. P., & Tefferi, A. (2002) · Acta Haematologica · doi:10.1159/000064754 · Cited by 49
An iron rheostat controls hematopoietic stem cell fate
Kao, Y.-R., Chen, J., Kumari, R., Ng, A. K. Y., Zintiridou, A., Tatiparthy, M., Ma, Y., Aivalioti, M. M., Moulik, D., Sundaravel, S., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.01.011 · Cited by 50
Clonal hematopoiesis, aging, and cardiovascular diseases
Pardali, E., Dimmeler, S., Zeiher, A. M., & Rieger, M. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.006 · Cited by 50
Kristiansen, M. B., Knudsen, G. P. S., Maguire, P., Margolin, S., Pedersen, J., Lindblom, A., & Ørstavik, K. H. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.032433 · Cited by 48
Ochiai, T., Urata, Y., Yamano, T., Yamagishi, H., & Ashihara, T. (2000) · Hepatology · doi:10.1002/hep.510310311 · Cited by 48
Sujobert, P., Cuccuini, W., Vignon-Pennamen, D., Martin‐Garcia, N., Albertini, A. F., Uzunov, M., Redjoul, R., Dombret, H., & Raffoux, E. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.408 · Cited by 47
Advances in the diagnosis and treatment of chronic granulomatous disease
Seger, R. A. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32834115e7 · Cited by 47
Clonal Hematopoiesis and Its Impact on Cardiovascular Disease
Sano, S., Wang, Y., & Walsh, K. X. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0871 · Cited by 50
Changing mutational and adaptive landscapes and the genesis of cancer
Liggett, L. A., & DeGregori, J. V. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.01.005 · Cited by 48
Chen, B., Craiu, R. V., Strug, L. J., & Sun, L. (2021) · Genetic Epidemiology · doi:10.1002/gepi.22422 · Cited by 43
The X Chromosome and the Female Survival Advantage
Christensen, K., Ørstavik, K. H., & Vaupel, J. W. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb02752.x · Cited by 46
X-inactivation patterns in carriers of X-linked myotubular myopathy
Kristiansen, M. B., Knudsen, G. P., Tanner, S. M., McEntagart, M., Jungbluth, H., Muntoni, F., Sewry, C. A., Gallati, S., Örstavik, K. H., & Wallgren‐Pettersson, C. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00067-1 · Cited by 47
Chagnon, P., Schneider, R., Hébert, J., Fortin, P. R., Provost, S., Bélisle, C., Gingras, M., Bolduc, V., Perreault, C., Silverman, E. D., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21733 · Cited by 46
Self-citationBench, A. J., Cross, N. C. P., Huntly, B. J. P., Nacheva, E. P., & Green, A. R. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2001.0153 · Cited by 46
X Chromosome Inactivation Patterns in Normal Females
Racchi, O., Mangerini, R., Rapezzi, D., Rolfo, M., Gaetani, G. F., & Ferraris, A. M. (1998) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1998.0213 · Cited by 46
Raskind, W. H., Steinmann, L., & Najfeld, V. (1998) · Leukemia · doi:10.1038/sj.leu.2400934 · Cited by 45
A Longitudinal Twin Study of Skewed X Chromosome-Inactivation
Wong, C. C. Y., Caspi, A., Williams, B. S., Houts, R., Craig, I., & Mill, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017873 · Cited by 44
Buscarlet, M., Tessier, A., Provost, S., Mollica, L. R., & Busque, L. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.07.009 · Cited by 45
Self-citationClonal hematopoiesis: Pre-cancer PLUS
Silver, A. J., & Jaiswal, S. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2018.12.003 · Cited by 46
Rimsza, L., Kopecky, K., Ruschulte, J., Chen, I.-M., Slovak, M., Karanes, C., Godwin, J. E., List, A. F., & Willman, C. (2000) · Leukemia · doi:10.1038/sj.leu.2401699 · Cited by 44
Rocha, R. O., Billerbeck, A. E. C., Pinto, E. M., Melo, K. F. S., Lin, C. J., Longui, C. A., Mendonca, B. B., & Bachega, T. A. S. S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03023.x · Cited by 43
Wei, H., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., McKay, J., Field, J. K., Amos, C. I., & Cheng, C. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1903 · Cited by 45
Germline PTEN mutation in a family with Cowden syndrome and Bannayan‐Riley‐Ruvalcaba Syndrome
Zori, R. T., Marsh, D. J., Graham, G. E., Marliss, E. B., & Eng, C. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19981204)80:4 · Cited by 111
Clonality analysis by methylation-specific PCR for the human androgen-receptor gene (HUMARA-MSP)
Uchida, T., Ohashi, H., Aoki, E., Nakahara, Y., Hotta, T., Murate, T., Saito, H., & Kinoshita, T. (2000) · Leukemia · doi:10.1038/sj.leu.2401631 · Cited by 43
Clonality in the Myelodysplastic Syndromes
Boultwood, J., & Wainscoat, J. S. (2001) · International Journal of Hematology · doi:10.1007/bf02994002 · Cited by 43
Ferfouri, F., Bernicot, I., Schneider, A., Haquet, E., Hedon, B., & Anahory, T. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.12.013 · Cited by 42
Delforge, M., Demuynck, H., Verhoef, G. E. G., Vandenberghe, P., Zachée, P., Maertens, J. A., Duppen, V. V., & Boogaerts, M. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00797.x · Cited by 42
Age acquired skewed X chromosome inactivation is associated with adverse health outcomes in humans
Roberts, A. L., Morea, A., Amar, A., Zito, A., Moustafa, J. S. E.-S., Tomlinson, M., Bowyer, R. C. E., Zhang, X., Christiansen, C., Costeira, R., et al. (2022) · eLife · doi:10.7554/elife.78263 · Cited by 44
Bernard, L., Bélisle, C., Mollica, L. R., Provost, S., Roy, D.-C., Gilliland, D. G., Levine, R. L., & Busque, L. (2008) · Leukemia · doi:10.1038/leu.2008.319 · Cited by 40
Self-citationEpigenetics of hematopoietic stem cell aging and disease
Oshima, M., & Iwama, A. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1647-2 · Cited by 39
Clonal hematopoiesis and preleukemia—Genetics, biology, and clinical implications
Hartmann, L., & Metzeler, K. H. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22756 · Cited by 42
Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?
Bejar, R. L. (2015) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-015-0270-5 · Cited by 40
Metadata
- Authors
- Busque, L., Mio, R., Mattioli, J., Brais, E., Blais, N., Lalonde, Y., Maragh, M., & Gilliland, D.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Research Center, Hopital Maisonneuve-Rosemont, University of Montreal, Quebec, Canada.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1996-07-01
- Volume
- 88
- Issue
- 1
- Pages
- 59-65
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W4242239767
- Cited by
- 543
- References
- 35
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 29 · 2020: 24 · 2019: 29 · 2018: 30 · 2017: 22 · 2016: 17 · 2015: 12 · 2014: 16 · 2013: 7 · 2012: 11
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA47261)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- X chromosome inactivation, X-inactivation skewing, heterozygous females, stem cell depletion, clonal hematopoiesis, neonates, healthy women, blood cells, X-inactivation patterns
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Base Sequence, Clone Cells, Dosage Compensation, Genetic, Female, Heterozygote, Humans, Infant, Newborn, Methylation, Middle Aged, Models, Biological, Molecular Sequence Data, Phosphoglycerate Kinase, Transcription Factors, Polymerase Chain Reaction, Artifacts, Cell Lineage, RNA, Untranslated, RNA, Long Noncoding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review